Literature DB >> 1739079

Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis.

A Bonnardeaux1, V Pichette, D Ouimet, D Geadah, F Habel, J Cardinal.   

Abstract

The purpose of this study was to determine the effects of high inlet dialysate flow rates (IDFR) on the clearances of urea and creatinine and to measure the absorption of glucose through the dialyzer in continuous arteriovenous hemodialysis (CAVHD). Ten anuric acute renal failure patients in the intensive care unit were studied. Increasing the IDFR from 0 to 33.3 mL/min (0 to 2 L/h) produced linear increments in the clearances of urea and creatinine, whereas further increases in the IDFR from 33.3 to 66.7 mL/min (2 to 4 L/h) produced less important, but still significant, increases in the clearances. At 66.7 mL/min, the clearances for urea and creatinine were 48.5 +/- 3.4 and 42.2 +/- 2.5 mL/min, respectively. Using a dialysate with a glucose concentration of 25.3 mmol/L (0.5 g/dL), the net transfer of glucose through the dialyzer did not change significantly, from 16.7 to 66.7 mL/min of IDFR. Increasing the inlet dialysate glucose concentration from 25.3 to 75.8, 126.3, and 214.6 mmol/L (0.5 to 1.5, 2.5, and 4.25 g/dL) at a fixed IDFR of 16.7 mL/min produced linear increments in the net glucose transferred to the patient, from 0.12 +/- 0.02 to 0.67 +/- 0.05, 1.25 +/- 0.06 and 2.30 +/- 0.14 mmol/min, respectively (21.4, 121.0, 225.7, and 414.5 mg/min). No significant changes in the ultrafiltration and plasma flow rates through the dialyzer were recorded at these different IDFR or inlet dialysate glucose concentrations. Ten patients were treated for 4 days or more with 16.7 mL/min (1 L/h) IDFR CAVHD with excellent control over kidney function parameters.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739079     DOI: 10.1016/s0272-6386(12)70199-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  Metabolic disturbances following the use of inadequate solutions for hemofiltration in acute renal failure.

Authors:  Demet Demirkol Soysal; Metin Karaböcüoğlu; Agop Citak; Raif Uçsel; Nedret Uzel; Ahmet Nayir
Journal:  Pediatr Nephrol       Date:  2006-12-05       Impact factor: 3.714

2.  CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations.

Authors:  Anna Lorenzin; Francesco Garzotto; Alberta Alghisi; Mauro Neri; Dario Galeano; Stefania Aresu; Antonello Pani; Enrico Vidal; Zaccaroa Ricci; Luisa Murer; Stuart L Goldstein; Claudio Ronco
Journal:  Pediatr Nephrol       Date:  2016-04-30       Impact factor: 3.714

Review 3.  A review of continuous renal replacement therapy.

Authors:  C G Flynn
Journal:  Ir J Med Sci       Date:  1994-07       Impact factor: 1.568

4.  Comparing risk of new onset diabetes mellitus in chronic kidney disease patients receiving peritoneal dialysis and hemodialysis using propensity score matching.

Authors:  Che-Yi Chou; Chih-Chia Liang; Huey-Liang Kuo; Chiz-Tzung Chang; Jiung-Hsiun Liu; Hsin-Hung Lin; I-Kuan Wang; Ya-Fei Yang; Chiu-Ching Huang
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

5.  Kidney Replacement Therapy in COVID-19 Induced Kidney Failure and Septic Shock: A Pediatric Continuous Renal Replacement Therapy [PCRRT] Position on Emergency Preparedness With Resource Allocation.

Authors:  Rupesh Raina; Ronith Chakraborty; Sidharth Kumar Sethi; Timothy Bunchman
Journal:  Front Pediatr       Date:  2020-07-03       Impact factor: 3.418

Review 6.  Bench-to-bedside review: metabolism and nutrition.

Authors:  Michaël P Casaer; Dieter Mesotten; Miet R C Schetz
Journal:  Crit Care       Date:  2008-08-19       Impact factor: 9.097

7.  Calorie intake and patient outcomes in severe acute kidney injury: findings from The Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy (RENAL) study trial.

Authors:  Rinaldo Bellomo; Alan Cass; Louise Cole; Simon Finfer; Martin Gallagher; Joanne Lee; Serigne Lo; Colin McArthur; Shay McGuinness; John Myburgh; Robyn Norton; Carlos Scheinkestel; Steve Su
Journal:  Crit Care       Date:  2014-03-14       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.